A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The breakpoints of Df(3R)BSC794 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}Takr99Df02797 and P{XP}CG7920d05544 insertion sites are 3R:25784120 ;25838384 and the cytological breakpoints predicted from these coordinates are 99D1;99D1.